Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Total Debt (2022 - 2024)

Adaptin Bio (APTN) posted Total Debt of $1.2 million for Q4 2024, up 3928.09% sequentially from $31000.0 in Q3 2024, and up 12387.08% YoY from N/an in Q1 2024.

Adaptin Bio (APTN) Total Debt (2022 - 2024) Analysis & Trends

Adaptin Bio has reported Total Debt for 3 years, with the latest figure at $1.2 million in Q4 2024.

  • Quarterly Total Debt rose 12387.08% year-over-year to $1.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.2 million (up 12387.08% YoY) and the FY2024 annual result came in at $1.2 million, up 12387.08% from the prior year.
  • Total Debt grew to $1.2 million in Q4 2024 per APTN's latest filing, from $31000.0 in the prior quarter.
  • Over five years, Total Debt peaked at $1.2 million in Q4 2024 and troughed at $5000.0 in Q4 2022.
  • A 3-year average of $203275.3 and a median of $28000.0 in 2024 frame the typical range for Total Debt.
  • The widest YoY moves for Total Debt: up 12387.08% in 2024, down 63.16% in 2024.
  • Over 3 years, Total Debt stood at $5000.0 in 2022, then surged by 100.0% to $10000.0 in 2023, then soared by 12387.08% to $1.2 million in 2024.
  • According to Business Quant data, Total Debt over the past three periods registered $1.2 million, $31000.0, and $28000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2024 1.25 Mn
Sep 30, 2024 31,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 81,219.00
Dec 31, 2023 10,000.00
Sep 30, 2023 19,000.00
Dec 31, 2022 5,000.00